Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy, safety and tolerability of RX-3341
(delafloxacin), a fluoroquinolone, versus tigecycline, a glycylcycline antibacterial drug, in
the treatment of complicated skin and skin structure infections.